The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischaemia-reperfusion injury in the pig

被引:48
作者
Louttit, JB [1 ]
Hunt, AAE [1 ]
Maxwell, MP [1 ]
Drew, GM [1 ]
机构
[1] Glaxo Wellcome Res & Dev Ltd, Med Res Ctr, Syst Biol Unit, Stevenage SG1 2NY, Herts, England
关键词
cardioprotection; adenosine A(1)-receptor; ischaemia; reperfusion; GR79236; pig;
D O I
10.1097/00005344-199902000-00016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cardioprotective effects of the selective adenosine A(1)-receptor agonist, GR79236 (N-[(1S, trans)-2-hydroxycyclopentyl]adenosine), were examined in a porcine model of myocardial ischaemia-reperfusion injury. When pigs were subjected to a 50-min coronary artery occlusion followed by 3-h reperfusion, GR79236 (10 nmol/kg, i.v.) significantly reduced infarct size whether given 10 min before the onset of ischaemia or reperfusion. This effect was independent of the bradycardia induced by GR79236, as it was also observed in animals in which heart rate was maintained by electrical pacing. However, GR79236 administered 10 min after reperfusion did not reduce infarct size. GR79236 had no effect on the incidence or outcome of ventricular dysrhythmias in this pig model of infarction. Similarly, ischaemic preconditioning (IPC, 2 x 10-min ischaemia and 10-min reperfusion) significantly reduced infarct size. The selective adenosine Al-receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 3.3 mu mol/kg, i.v.), abolished the haemodynamic and cardioprotective effects of GR79236 and the cardioprotective effects of IPC in anaesthetised pigs. In conclusion, GR79236 exerted a marked cardioprotective effect in a porcine model of myocardial ischaemia-reperfusion injury, provided that it was administered before reperfusion. This suggests that GR79236 may have clinical utility in the treatment of various aspects of ischaemic heart disease.
引用
收藏
页码:285 / 291
页数:7
相关论文
共 29 条
[11]   AN ADENOSINE-A1-RECEPTOR AGONIST, R(-)-N-(2-PHENYLISOPROPYL)-ADENOSINE (PIA), BUT NOT ADENOSINE ITSELF, ACTS AS A THERAPEUTIC PRECONDITIONING-MIMETIC AGENT IN RABBITS [J].
HALE, SL ;
BELLOWS, SD ;
HAMMERMAN, H ;
KLONER, RA .
CARDIOVASCULAR RESEARCH, 1993, 27 (12) :2140-2145
[12]  
Hunt AAE, 1997, BRIT J PHARMACOL, V120, pP180
[13]   EFFECT OF INHIBITION OF LIPOLYSIS ON INFARCT SIZE AFTER EXPERIMENTAL CORONARY-ARTERY OCCLUSION [J].
KJEKSHUS, JK ;
MJOS, OD .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (07) :1770-1778
[14]   PRECONDITIONING - STATE-OF-THE-ART MYOCARDIAL PROTECTION [J].
LAWSON, CS ;
DOWNEY, JM .
CARDIOVASCULAR RESEARCH, 1993, 27 (04) :542-550
[15]   PROTECTION AGAINST INFARCTION AFFORDED BY PRECONDITIONING IS MEDIATED BY A1 ADENOSINE RECEPTORS IN RABBIT HEART [J].
LIU, GS ;
THORNTON, J ;
VANWINKLE, DM ;
STANLEY, AWH ;
OLSSON, RA ;
DOWNEY, JM .
CIRCULATION, 1991, 84 (01) :350-356
[16]  
MARTIN BJ, 1993, CIRCULATION, V88, P430
[17]   SPECIES VARIATION IN THE CORONARY COLLATERAL CIRCULATION DURING REGIONAL MYOCARDIAL-ISCHEMIA - A CRITICAL DETERMINANT OF THE RATE OF EVOLUTION AND EXTENT OF MYOCARDIAL-INFARCTION [J].
MAXWELL, MP ;
HEARSE, DJ ;
YELLON, DM .
CARDIOVASCULAR RESEARCH, 1987, 21 (10) :737-746
[18]   PRECONDITIONING WITH ISCHEMIA - A DELAY OF LETHAL CELL INJURY IN ISCHEMIC MYOCARDIUM [J].
MURRY, CE ;
JENNINGS, RB ;
REIMER, KA .
CIRCULATION, 1986, 74 (05) :1124-1136
[19]   HEMODYNAMIC PREDICTORS OF MYOCARDIAL OXYGEN-CONSUMPTION DURING STATIC AND DYNAMIC EXERCISE [J].
NELSON, RR ;
GOBEL, FL ;
JORGENSEN, CR ;
WANG, K ;
WANG, Y ;
TAYLOR, HL .
CIRCULATION, 1974, 50 (06) :1179-1189
[20]   THE EFFECTS OF INTRAVENOUS INFUSIONS OF SELECTIVE ADENOSINE-A1-RECEPTOR AND A2-RECEPTOR AGONISTS ON MYOCARDIAL REPERFUSION INJURY [J].
NORTON, ED ;
JACKSON, EK ;
TURNER, MB ;
VIRMANI, R ;
FORMAN, MB .
AMERICAN HEART JOURNAL, 1992, 123 (02) :332-338